Surgery – Means for introducing or removing material from body for... – Material introduced into and removed from body through...
Patent
1998-05-04
2000-05-02
Mendez, Manuel
Surgery
Means for introducing or removing material from body for...
Material introduced into and removed from body through...
A61M 3100
Patent
active
060567155
ABSTRACT:
A method and solution for perioperatively inhibiting a variety of pain and inflammation processes at wounds from general surgical procedures including oral/dental procedures. The solution preferably includes multiple pain and inflammation inhibitory at dilute concentration in a physiologic carrier, such as saline or lactated Ringer's solution. The solution is applied by continuous irrigation of a wound during a surgical procedure for preemptive inhibition of pain and while avoiding undesirable side effects associated with oral, intramuscular, subcutaneous or intravenous application of larger doses of the agents. One preferred solution to inhibit pain and inflammation includes a serotonin.sub.2 antagonist, a serotonin.sub.3 antagonist, a histamine antagonist, a serotonin agonist, a cyclooxygenase inhibitor, a neurokinin.sub.1 antagonist, a neurokinin.sub.2 antagonist, a purinoceptor antagonist, an ATP-sensitive potassium channel opener, a calcium channel antagonist, a bradykinin.sub.1 antagonist, a bradykinin.sub.2 antagonist and a .mu.-opioid agonist.
REFERENCES:
patent: 4490379 (1984-12-01), Podos et al.
patent: 4504493 (1985-03-01), Marshall et al.
patent: 4525359 (1985-06-01), Greenway, III et al.
patent: 4659714 (1987-04-01), Watt-Smith
patent: 4880791 (1989-11-01), Weithmann et al.
patent: 5051443 (1991-09-01), Neufeld et al.
patent: 5272139 (1993-12-01), Cary
patent: 5288725 (1994-02-01), Witherup et al.
patent: 5350761 (1994-09-01), Van Duzer et al.
patent: 5411743 (1995-05-01), Moore et al.
patent: 5468505 (1995-11-01), Hubbell et al.
patent: 5502080 (1996-03-01), Hitzig
patent: 5502082 (1996-03-01), Unger et al.
patent: 5512055 (1996-04-01), Domb et al.
patent: 5536241 (1996-07-01), Zapol
patent: 5618563 (1997-04-01), Berde et al.
patent: 5658955 (1997-08-01), Hitzig
patent: 5744482 (1998-04-01), Cohen et al.
Thulesius, O., et al., "Ketanserin in intermittent claudication: effect on walking distance, blood pressure, and cardiovascular complications," J. Cardiovasc. Pharmacol, 9:728-733 (1987).
Hedner, T., et al., "Effects of a new serotonin antagonist, Ketanserin, in experimental and clinical hypertension," Am. J. Hypertens. 1:317S-323S (1988).
Hof, R.P., et al., "Antiarrhythmic and hemodynamic effects of tropisetron in anesthetized rabbits," J. Cardiovasc. Pharmacol 22:449-505 (1993).
Naesh, O., et al., "Platelet activation in mental stress," Clin. Physiol. 13:299-307 (1993).
Evans, R.G., et al., "Effects of 5-HT-receptor and alpha 2-androceptor ligands on the haemodynamic response to acute central hypovolemia in conscious rabbits," Br. J. Pharmacol. 109:37-47 (1993).
Van Hemelrijck, J., et al., "Blood pressure management during aortic surgery: urapidil compared to isosorbide dinitrate," J. Cardiothorac. Vasc. Anesth. 7:273-278 (1993).
Evans, R.G., et al., "A CNS serotonergic mechanism in acute central hypovolemia in conscious rabbits?" J. Cardiovasc. Pharmacol. 19:1009-1017 (1992).
Vyssoulis, G.P., et al., "Left ventricular hypertrophy regression and function changes with ketanserin in elderly hypertensives," Cardiovasc. Drugs Ther. 4:81-84 (1990).
Sigal, S.L., et al., "Effects of Serotonin-Receptor Blockade on Angioplasty-Induced Vasospasm in an Atherosclerotic Rabbit Model," Arterioscler. Thrombosis, 11:770-783 (1991).
Kalsner, S., et al., "Coronary arteries of cardiac patients are hyperreactive and contain stores of amines: a mechanism for coronary spasm," Science, 223:1435-1437 (1984).
Willerson, J.T., et al., "Specific Platelet mediators and unstable coronary artery lesions," Circulation, 80:198-205 (1989).
Saxena, P.R., et al., "Cardiovascular effects on serotonin agonists and antagonists," J. Cardiovasc. Pharmacol. 15:S17-S34 (1990).
Ashton, J.H., et al., "Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries," circulation, 73:572-578 (1986).
Douglas, W.W. "Histamine and 5-hydroxytryptamine (serotonin) and their antagonists," In: The Pharmacological Basis of Therapeutics 605-638 (1985).
Kessler, W., et al., "Excitation of cutaneous afferent nerve endings in vitro by a combination of inflammatory mediators and conditioning effect of substance P," Exp. Brain Res. 91:467-476 (1992).
Lang, E., et al., "Chemosensitivity of fine afferents from rat skin in vitro," J. Neurophysiol. 63:887-901 (1990).
Levine, J.D., et al., "Desipramine enhances opiate postoperative analgesia," Pain, 27:45-49 (1986).
Richardson, B.P., et al., "Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs," Nature, 316:126-131 (1985).
Ringkamp, M., et al., "Activated human platelets in plasma excite nociceptors in rat skin, in vitro," Neurosci, Letti. 170:103-106 (1994).
Buzzi, M.G., et al., "the antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater," Br. J. Pharmacol. 99:202-206 (1990).
Buzzi, M.G., et al., "5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation," Brain Res. 137-149 (1992).
Zochodne, D.W., et al., "Summatriptan blocks neurogenic inflammation i the peripheral nerve trunk," Neurology, 44:161-163 (1994).
Schwartz, M.M., et al., "Vascular leakage in the kidney and lower urinary tract: effects of histamine, serotonin and bradykinin," Proc. Soc. Exp. Biol. Med. 140:535-539 (1972).
Hilliman, C.J., et al., "The effect of ketanserin, a specific serotonin antagonist, on burn shock hemodynamic parameters in a porcine burn model," J. Trauma, 23:867-871 (1983).
Serruys, P.W., et al., "Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty; a multicenter randomized double-blind placebo-controlled trial," Circulation, 88:1588-1601 (1993).
Cohen, B.M., et al., "Intracoronary cocktail infusion during rotational ablation: safety and efficacy," Transcatheter Cardiovascular Therapeutics (1995).
Berkenboom, G., et al., "Atherosclerosis and responses of human isolated coronary arteries to endothelium-dependent and -independent vasodilators," J. Cardiovasc. Pharmacol. 14:S35-S39 (1989).
Kaumann, A.J., et al., "Variable participation of 2HT1-like receptors and 5-HT1 receptors in serotonin-induced contraction of human isolated coronary arteries," Circulation, 90:1141-1153 (1994).
Quast, U., et al., "Cellular Pharmacology of Potassium Channel Openers in Vascular Smooth Muscle," Cardiovascular Research, 28:805-810 (1994).
Golino, P., et al., "Failure of nitrogylycerine and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A.sub.2 and serotonin as mediators of coronary artery vasoconstriction in vivo," J. Am. Coll. Cardiol. 15 :718-726 (1990).
DeCaterina, R., et al., "A Double-blind, Placebo-controlled Study of Ketanserin in Patients with Prinzmetal's Angima," Circulation, 69:889-894 (1984).
Golino, P., et al., "Divergent Effects of Serotonin on Coronary-Artery Dimensions and Blood Flow in Patients with Coronary Artherosclerosis and Control Patients," New Engl. J. Med. 324:641-648 (1991).
Golino, P., et al., "Local Effect of Serotonin Released During Coronary Angioplasty," New Engl. J. Med. 330:523-528 (1994).
Ashton, J.H., et al., "Serotonin S.sub.2 and Thromboxane A.sub.2 -Prostaglandid H.sub.2 Receptor Blockade Provide Protection Against Epinephrine-Induced Cyclic Flow Variations in Severly Narrowed Canine Coronary Arteries," J. Am. Coll. Cardiol. 13:755-763 (1989).
Yao, S., et al., "Comnibed ADP and Thromboxane A.sub.2 Antagonism Prevents Cyclic Flow Variations is Stenosed and Endothelium-Injured Arteries in Nonhuman Primates," Circulation, 88:2888-2893 (1993).
Cohen, B.M., et al., "Cocktail attenuation of rotational ablation flow effects (CARAFE) study: pilot," Cathet. Cardiovasc. Diagn. Suppl.3:69-72 (1996).
Sosnowski, M., et al., "Spinal Administration of Receptor-Selective Drugs as Analgesics: New Horizons," J. Pain Symptom Manag. 5:204-213 (1990).
Kuga, T.,
Demopulos Gregory A.
Herz Jeffrey M.
Pierce Pamela A.
Mendez Manuel
Omeros Medical Systems, Inc.
LandOfFree
Surgical irrigation solution and method for inhibition of pain a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Surgical irrigation solution and method for inhibition of pain a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Surgical irrigation solution and method for inhibition of pain a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1590623